Parallel Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Parallel Advisors’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10	Closed	-$1K	–	3649
2022 Q2	$1K	Buy	+10	New	+$444	﹤0.01%	2934
2022 Q1	–	Sell	-260	Closed	-$12K	–	3414
2021 Q4	$12K	Buy	260 +212	+442%	+$9.48K	﹤0.01%	2051
2021 Q3	$3K	Buy	+48	New	+$3.42K	﹤0.01%	2626

Parallel Advisors's TPTX Position: Q3 2022 in Review

Parallel Advisors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 10 shares — an estimated $1K sold.

Parallel Advisors first reported a position in TPTX in Q3 2021 and held it in 3 quarters. The position peaked at $12K in Q4 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Parallel Advisors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Parallel Advisors sold 10 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
Parallel Advisors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Parallel Advisors's Turning Point Therapeutics, Inc. Common Stock position peaked at $12K in Q4 2021.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Parallel Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.